| Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead D Kumar, A Ganeshpurkar, D Kumar, G Modi, SK Gupta, SK Singh European journal of medicinal chemistry 148, 436-452, 2018 | 167 | 2018 |
| Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease D Kumar, SK Gupta, A Ganeshpurkar, G Gutti, S Krishnamurthy, G Modi, ... European journal of medicinal chemistry 150, 87-101, 2018 | 65 | 2018 |
| Glycolytic enzyme inhibitory and antiglycation potential of rutin S Dubey, A Ganeshpurkar, A Ganeshpurkar, D Bansal, N Dubey Future Journal of Pharmaceutical Sciences 3 (2), 158-162, 2017 | 53 | 2017 |
| In vitro, in vivo and in silico antiulcer activity of ferulic acid R Umre, A Ganeshpurkar, A Ganeshpurkar, S Pandey, V Pandey, ... Future Journal of Pharmaceutical Sciences 4 (2), 248-253, 2018 | 46 | 2018 |
| Multiple 3D-QSAR modeling, e-pharmacophore, molecular docking, and in vitro study to explore novel AChE inhibitors S Jana, A Ganeshpurkar, SK Singh RSC Advances 8, 39477–39495, 2018 | 42 | 2018 |
| Development of pyrazole and spiropyrazoline analogs as multifunctional agents for treatment of Alzheimer’s disease G Gutti, D Kumar, P Paliwal, A Ganeshpurkar, K Lahre, A Kumar, ... Bioorganic Chemistry 90, 103080, 2019 | 34 | 2019 |
| Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics A Ganeshpurkar, A Ganeshpurkar, V Pandey, A Agnihotri, D Bansal, ... International journal of pharmaceutical investigation 4 (1), 1, 2014 | 33 | 2014 |
| Structure-based screening and molecular dynamics simulation studies for the identification of potential acetylcholinesterase inhibitors A Ganeshpurkar, R Singh, PG Gore, D Kumar, G Gutti, A Kumar, SK Singh Molecular Simulation 46 (3), 169-185, 2020 | 32 | 2020 |
| RNA-dependent RNA polymerases and their emerging roles in antiviral therapy A Ganeshpurkar, G Gutti, SK Singh Viral Polymerases, 1-42, 2019 | 31 | 2019 |
| Discovery of novel series of 2-substituted benzo [d] oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease G Gutti, R Kakarla, D Kumar, M Beohar, A Ganeshpurkar, A Kumar, ... European Journal of Medicinal Chemistry 182, 111613, 2019 | 30 | 2019 |
| Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer’s disease R Swetha, D Kumar, SK Gupta, A Ganeshpurkar, R Singh, G Gutti, ... Future Medicinal Chemistry 11 (24), 3161-3178, 2019 | 29 | 2019 |
| Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: recent concepts & roles P Ghosh, R Singh, A Ganeshpurkar, AV Pokle, R bhushan Singh, ... Neurochemistry International 151, 105212, 2021 | 27 | 2021 |
| Protein-protein interactions and aggregation inhibitors in Alzheimer’s disease A Ganeshpurkar, R Swetha, D Kumar, GP Gangaram, R Singh, G Gutti, ... Current topics in medicinal chemistry 19 (7), 501-533, 2019 | 26 | 2019 |
| Design, synthesis and collagenase inhibitory activity of some novel phenylglycine derivatives as metalloproteinase inhibitors A Ganeshpurkar, D Kumar, SK Singh International journal of biological macromolecules 107, 1491-1500, 2018 | 23 | 2018 |
| Identifying potential GluN2B subunit containing N-Methyl-D-aspartate receptor inhibitors: An integrative in silico and molecular modeling approach R Singh, A Ganeshpurkar, D Kumar, D Kumar, A Kumar, SK Singh Journal of Biomolecular Structure and Dynamics 38 (9), 2533-2545, 2019 | 22 | 2019 |
| Strategies for the synthesis of hydroxamic acids A Ganeshpurkar, D Kumar, SK Singh Current Organic Synthesis 15 (2), 154-165, 2018 | 22 | 2018 |
| Biological profiling of piperazinediones for the management of anxiety D Kumar, SK Gupta, A Ganeshpurkar, R Singh, D Kumar, N Das, ... Pharmacology Biochemistry and Behavior 176, 63-71, 2019 | 15 | 2019 |
| Syringic acid, a novel thyroid hormone receptor‐β agonist, ameliorates propylthiouracil‐induced thyroid toxicity in rats S Panda, A Kar, M Singh, RK Singh, A Ganeshpurkar Journal of biochemical and molecular toxicology 35 (8), e22814, 2021 | 14 | 2021 |
| Classification of beta‐site amyloid precursor protein cleaving enzyme 1 inhibitors by using machine learning methods R Singh, A Ganeshpurkar, P Ghosh, AV Pokle, D Kumar, R Singh, ... Chemical Biology & Drug Design 98 (6), 1079-1097, 2021 | 12 | 2021 |
| Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach A Ganeshpurkar, R Singh, D Kumar, P Gore, S Shivhare, D Sardana, ... International Journal of Biological Macromolecules 203, 195-211, 2022 | 10 | 2022 |
Prof. Sushil Kumar Singh, FRSCDepartment of Pharmaceutical Engineering & Technology, IIT(BHU, Varanasi在 itbhu.ac.in 的电子邮件经过验证
